Vaishali Pharma filed Annual Disclosure under SEBI Takeover Regulations 31(4) for FY ended 31st March 2026.
Promoter & Chairman Atul Arvindbhai Vasani confirmed zero encumbrance on shares by Promoter Group in FY2026.
Disclosure submitted to NSE by Company Secretary Vishwa Mekhia on 2nd April 2026.